In the most recently reported quarter, several renowned institutional investors made notable increases to their Danaher (DHR) holdings, reflecting growing confidence in the life sciences and diagnostics conglomerate. As the company continues to evolve its portfolio through innovation and strategic divestitures, Danaher is attracting fresh institutional capital as a long-term compounder in the healthcare sector.| The Acquirer's Multiple®
During his recent interview with The Bull of Wall Street Podcast, Cliff Asness explained why he is still placing his chips on value—albeit a more evolved version of it. “The value factor as quants and academics call it… is very incomplete,” he admits. “It drives non-quants crazy that quants call something like, at its simplest, price to book… value.”| The Acquirer's Multiple®